post-cal model adjust increas estim pipelin
updat estim zoeti follow compani fourth-quart earn
releas thursday morn quarter number ahead estim
guidanc ahead expect top bottom line result
increas revenu target million ep target year
appear market gener stabl present grow roughli despit
headwind beef dairi categori expect zoeti exceed
market growth rate believ robust pipelin commentari give
investor plenti chew look one two year
continu impress compani execut consist organ growth
market ratesuch fourth quarter increas though expect
growth rate companion anim dermatolog portfolio normal somewhat
believ overal busi still grow rang look
number product manag note pipelin
keep growth steadi rate move forward believ investor look
proof abaxiss growth rate diagnost improv
zoeti umbrella acquisit succe believ investor becom even
comfort compani continu outpac broader anim health market
midsingle-digit pace given diagnost tend fastest-grow product categori
maintain outperform rate zoeti given stabil busi model
encourag flow innov reason rel valuat
return equiti ttm
zoeti leader develop manufactur market anim health medicin vaccin
product companion anim market annual revenu exceed billion compani found
divis spun februari oper countri maintain one
largest budget industri
pleas refer import disclosur page analyst certif page
william blair affili seek busi compani cover research report
result investor awar firm may conflict interest could affect object
report report intend provid person invest advic opinion recommend
herein take account individu client circumst object need intend
recommend particular secur financi instrument strategi particular client recipi
report must make independ decis regard secur financi instrument mention
exhibit zoeti organ growth segment present
innov manag commentari around potenti combin flea tick heartworm product
simparica trio increment posit opinion compani note dozen blockbust product
seem quit comfort simparica trio would add total also believ portfolio
monoclon antibodi pipelin set compani well futur success understand veterinarian
oftentim prefer inject product get pet owner clinic improv complianc reduc
potenti leakag altern channel
companion anim apoquel cytopoint combin million revenu third quarter year-
over-year increas see exhibit total million sequenti believ product still
room steadi growth albeit normal rate manag note simparica cytopoint
exceed million sale see reason product grow well excess
market
exhibit companion anim organ growth geographi present
xxsourc compani report william blair compani report william blair william blair
exhibit quarterli apoquel cytopoint sale present
livestock livestock busi appear steadi present challeng cattleon beef
dairi sidesa appar weak spot present gener view broader livestock market
produc slower growth compar companion believ potenti precis livestock farm
diagnost livestock space medium long term add nice top-lin growth strategi
invest mode present could begin yield return start
exhibit livestock organ growth geographi present
xxsourc compani report compani report william blair william blair
exhibit livestock organ growth speci present
increas revenu estim million billion encompass higher
start point partli off-set reduct organ growth target
addit headwind foreign exchang increas oper margin assumpt
basi point result increas ep estim
valuat stock thought
zoeti trade time updat ep estim compar five-year averag time
forward earn smaller-cap anim health peer time higher-growth veterinari peer time
continu impress manag steadi execut flow innov result
maintain outperform rate zoeti model follow exhibit
xxsourc compani report william blair william blair
good gross gener research amort intang total oper oper expense/ incom pre-tax tax net loss attribut non-controlling interest- net incom excl non-recurring non-recurring item net net ep excl non-recurring per average share outstand margin analysi gross metric total revenu constant oper revenu constant incom excl non-recur excl non-recur share blair compani estimatesourc compani report william blair compani llc estim import disclosur
